Rx · PZN 04971976, 10022215, 01799620, 07757516…
TYSABRI 300 mg 20 mg/ml concentrate for preparation of a solution for infusion
German trade nameTYSABRI 300 mg 20 mg-ml Konzentrat zur Herstellung einer Infusionslösung
Consistently available
8.3out of 10
Storage temperature and transport temperature
Average purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
TYSABRI 300 mg 20 mg/ml concentrate for preparation of a solution for infusion is consistently available through wholesale. We are happy to review your purchase price and advise you on it.
Review purchasing termsTYSABRI 300 mg 20 mg/ml concentrate for preparation of a solution for infusion contains the active ingredient Natalizumab and comes as Concentrate for solution for infusion. 15 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 8.3 out of 10. The best-available pack was consistently available. 14 of the 15 packs are currently marketed according to our records.
Pack sizes · 15 PZN
| PZN | Index 7 d | Index 30 d | Highest known purchase price |
|---|---|---|---|
| 04971976 | 9.4 | 8.3 | ~ €2,439 |
| 07757516 | 4.9 | 5.2 | ~ €2,263 |
| 10022215 | 1.3 | 1.3 | ~ €2,261 |
| 15246557 | 1.3 | 1.3 | ~ €2,264 |
| 14166483 | 2.2 | 1.1 | ~ €2,263 |
| 00172296 | 0.7 | 0.7 | ~ €2,315 |
| 16678951 | 0.2 | 0.1 | ~ €2,261 |
| 01799620 | 0.0 | 0.0 | ~ €2,109 |
| 10949923 | 0.0 | 0.0 | ~ €1,896 |
| 00295656 | 0.0 | 0.0 | ~ €2,439 |
| 07265612 | 0.0 | 0.0 | ~ €2,132 |
| 14172905 | 0.0 | 0.0 | ~ €2,107 |
| 19857068 | 0.0 | 0.0 | ~ €2,121 |
| 13587923 | 0.0 | 0.0 | ~ €2,264 |
| 20548378 | 0.0 | 0.0 | ~ €2,263 |
We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.
Get in touch